These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 28178500)
21. [Protective effect of adeno-associated virus-mediated neurotrophin-3 on the cochlea of guinea pigs with gentamicin-induced hearing loss]. Yao XB; Li SL; Zhu HL; Wang XX; Liu H; Yan LY Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov; 27(11):1642-5. PubMed ID: 18024279 [TBL] [Abstract][Full Text] [Related]
22. [Comparison of gene transfer into the cochlea using adeno-associated virus versus adenovirus vectors]. Yang Y; Kong WJ; Hu YJ; Zhong Y; Zhao XY; Peng W Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1351-5. PubMed ID: 19615193 [TBL] [Abstract][Full Text] [Related]
23. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106 [TBL] [Abstract][Full Text] [Related]
24. Recombinant adeno-associated viral vector-mediated glial cell line-derived neurotrophic factor gene transfer protects nigral dopamine neurons after onset of progressive degeneration in a rat model of Parkinson's disease. Mandel RJ; Snyder RO; Leff SE Exp Neurol; 1999 Nov; 160(1):205-14. PubMed ID: 10630205 [TBL] [Abstract][Full Text] [Related]
25. Absence of hair cell protection by exogenous FGF-1 and FGF-2 delivered to guinea pig cochlea in vivo. Yamasoba T; Altschuler RA; Raphael Y; Miller AL; Shoji F; Miller JM Noise Health; 2001; 3(11):65-78. PubMed ID: 12689449 [TBL] [Abstract][Full Text] [Related]
26. A protein derived from the fusion of TAT peptide and FNK, a Bcl-x(L) derivative, prevents cochlear hair cell death from aminoglycoside ototoxicity in vivo. Kashio A; Sakamoto T; Suzukawa K; Asoh S; Ohta S; Yamasoba T J Neurosci Res; 2007 May; 85(7):1403-12. PubMed ID: 17387707 [TBL] [Abstract][Full Text] [Related]
27. Noninvasive in vivo delivery of transgene via adeno-associated virus into supporting cells of the neonatal mouse cochlea. Iizuka T; Kanzaki S; Mochizuki H; Inoshita A; Narui Y; Furukawa M; Kusunoki T; Saji M; Ogawa K; Ikeda K Hum Gene Ther; 2008 Apr; 19(4):384-90. PubMed ID: 18439125 [TBL] [Abstract][Full Text] [Related]
28. Regulated delivery of glial cell line-derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector. Georgievska B; Jakobsson J; Persson E; Ericson C; Kirik D; Lundberg C Hum Gene Ther; 2004 Oct; 15(10):934-44. PubMed ID: 15585109 [TBL] [Abstract][Full Text] [Related]
29. Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus. Lalwani A; Walsh B; Reilly P; Carvalho G; Zolotukhin S; Muzyczka N; Mhatre A Gene Ther; 1998 Feb; 5(2):277-81. PubMed ID: 9578849 [TBL] [Abstract][Full Text] [Related]
31. Doxycycline-regulated co-expression of GDNF and TH in PC12 cells. Wang JJ; Zhang T; Niu DB; Wang K; Li KR; Xue B; Wang XM Neurosci Lett; 2006 Jun; 401(1-2):142-5. PubMed ID: 16584838 [TBL] [Abstract][Full Text] [Related]
32. Intrastriatal GDNF gene transfer by inducible lentivirus vectors protects dopaminergic neurons in a rat model of parkinsonism. Chen SS; Yang C; Hao F; Li C; Lu T; Zhao LR; Duan WM Exp Neurol; 2014 Nov; 261():87-96. PubMed ID: 24997241 [TBL] [Abstract][Full Text] [Related]
33. [The transduction of neurotrophin-3/GDNF attenuates the SGNC damage in deaf mice]. Chen XW; Li H; Cao KL; Wei CG; Jin X Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1517-20. PubMed ID: 14521734 [TBL] [Abstract][Full Text] [Related]
34. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model. Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608 [TBL] [Abstract][Full Text] [Related]
35. Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. Natsume A; Mata M; Wolfe D; Oligino T; Goss J; Huang S; Glorioso J; Fink DJ J Neurotrauma; 2002 Jan; 19(1):61-8. PubMed ID: 11852979 [TBL] [Abstract][Full Text] [Related]
36. Gene-based therapy for inner ear disease. Kawamoto K; Kanzaki S; Yagi M; Stöver T; Prieskorn DM; Dolan DF; Miller JM; Raphael Y Noise Health; 2001; 3(11):37-47. PubMed ID: 12689447 [TBL] [Abstract][Full Text] [Related]
37. Protection against cisplatin-induced ototoxicity by adeno-associated virus-mediated delivery of the X-linked inhibitor of apoptosis protein is not dependent on caspase inhibition. Chan DK; Lieberman DM; Musatov S; Goldfein JA; Selesnick SH; Kaplitt MG Otol Neurotol; 2007 Apr; 28(3):417-25. PubMed ID: 17211286 [TBL] [Abstract][Full Text] [Related]
38. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Lalwani AK; Walsh BJ; Reilly PG; Muzyczka N; Mhatre AN Gene Ther; 1996 Jul; 3(7):588-92. PubMed ID: 8818645 [TBL] [Abstract][Full Text] [Related]
39. Gene transfer into guinea pig cochlea using adeno-associated virus vectors. Konishi M; Kawamoto K; Izumikawa M; Kuriyama H; Yamashita T J Gene Med; 2008 Jun; 10(6):610-8. PubMed ID: 18338819 [TBL] [Abstract][Full Text] [Related]
40. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. Peden CS; Burger C; Muzyczka N; Mandel RJ J Virol; 2004 Jun; 78(12):6344-59. PubMed ID: 15163728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]